Repository logo
 
Publication

EUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP care

dc.contributor.authorHellings, Peter
dc.contributor.authorAlobid, Isam
dc.contributor.authorAnselmo‐Lima, Wilma T.
dc.contributor.authorBernal‐Sprekelsen, Manuel
dc.contributor.authorBjermer, Leif
dc.contributor.authorCaulley, Lisa
dc.contributor.authorChaker, Adam
dc.contributor.authorConstantinidis, Jannis
dc.contributor.authorConti, Lucio
dc.contributor.authorDe Corso, Eugenio
dc.contributor.authorDesrosiers, Martin
dc.contributor.authorDiamant, Zuzana
dc.contributor.authorGevaert, Philippe
dc.contributor.authorHan, Jie
dc.contributor.authorHeffler, Enrico
dc.contributor.authorHopkins, Claire
dc.contributor.authorLandis, Basile
dc.contributor.authorLourenço, Olga
dc.contributor.authorLund, Valerie
dc.contributor.authorLuong, Amber U.
dc.contributor.authorMullol, Joaquim
dc.contributor.authorPeters, Anju
dc.contributor.authorPhilpott, Carl
dc.contributor.authorReitsma, Sietze
dc.contributor.authorRyan, Dermot
dc.contributor.authorScadding, Glenis
dc.contributor.authorSenior, Brent
dc.contributor.authorTomazic, Peter Valentin
dc.contributor.authorToskala, Elina
dc.contributor.authorVan Zele, Thibaut
dc.contributor.authorViskens, An‐Sofie
dc.contributor.authorWagenmann, Martin
dc.contributor.authorFokkens, Wytske
dc.date.accessioned2024-01-16T15:50:02Z
dc.date.available2024-01-16T15:50:02Z
dc.date.issued2024
dc.description.abstractFollowing the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) treatment algorithm for chronic rhinosinusitis (CRS) with nasal polyps (CRSwNP), patients suffering from severe uncontrolled CRSwNP are recommended to receive oral corticosteroids, (revision) sinus surgery, systemic biologicals and/or aspirin treatment after desensitization (ATAD). Given the major differences in indications, outcomes, practical considerations, risks and costs of these key pillars of treatment, there is a growing need to define criteria for each treatment option and list the clinically relevant and major considerations for them. This EUFOREA document therefore provides an expert panel overview of the expected outcomes, specific considerations and (contra)indications of the five major treatment arms of severe uncontrolled CRSwNP: oral corticosteroids, primary and revision sinus surgery, biological treatment and ATAD. This overview of treatment considerations is needed to allow physicians and patients to consider the different options in the context of providing optimal and personalized care for severe uncontrolled CRSwNP. In conclusion, the five major treatment options for severe uncontrolled CRSwNP have intrinsic advantages, specific indications and considerations that are of importance to the patient, the physician and the society. This EUFOREA statement supports the unmet need to define criteria for the indication of every treatment pillar of CRSwNP.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.doi10.1111/all.15982pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.6/14081
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.subjectAspirin intolerancept_PT
dc.subjectCorticosteroidspt_PT
dc.subjectBiologicspt_PT
dc.subjectCRSwNPpt_PT
dc.subjectSinus surgerypt_PT
dc.titleEUFOREA/EPOS2020 statement on the clinical considerations for CRSwNP carept_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.titleAllergypt_PT
person.familyNameHellings
person.familyNameAlobid
person.familyNameBjermer
person.familyNameCaulley
person.familyNameChaker
person.familyNameConstantinidis
person.familyNameConti
person.familyNameDesrosiers
person.familyNameDiamant
person.familyNameGevaert
person.familyNameHan
person.familyNameHeffler
person.familyNameHopkins
person.familyNameLandis
person.familyNameLourenço
person.familyNameLund
person.familyNameMullol
person.familyNamePeters
person.familyNamePhilpott
person.familyNameReitsma
person.familyNameRyan
person.familyNameScadding
person.familyNameSenior
person.familyNameTomazic
person.familyNameToskala
person.familyNameFokkens
person.givenNamePeter
person.givenNameIsam
person.givenNameLeif
person.givenNameLisa
person.givenNameAdam
person.givenNameJannis
person.givenNameLucio
person.givenNameMartin
person.givenNameZuzana
person.givenNamePhilippe
person.givenNameJie
person.givenNameEnrico
person.givenNameClaire
person.givenNameBasile
person.givenNameOlga
person.givenNameValerie
person.givenNameJoaquim
person.givenNameAnju
person.givenNameCarl
person.givenNameSietze
person.givenNameDermot
person.givenNameGlenis
person.givenNameBrent
person.givenNamePeter Valentin
person.givenNameElina
person.givenNameWytske
person.identifier489094
person.identifier1007152
person.identifier932235
person.identifier.ciencia-id6618-1C4C-D1B7
person.identifier.orcid0000-0001-6898-688X
person.identifier.orcid0000-0002-0273-3422
person.identifier.orcid0000-0002-3441-8099
person.identifier.orcid0000-0002-9661-4634
person.identifier.orcid0000-0002-5117-4073
person.identifier.orcid0000-0002-2369-993X
person.identifier.orcid0000-0002-7837-4227
person.identifier.orcid0000-0003-3774-2959
person.identifier.orcid0000-0003-0133-0100
person.identifier.orcid0000-0002-1629-8468
person.identifier.orcid0000-0002-2013-2962
person.identifier.orcid0000-0002-0492-5663
person.identifier.orcid0000-0003-3993-1569
person.identifier.orcid0000-0001-6034-3724
person.identifier.orcid0000-0002-8401-5976
person.identifier.orcid0000-0002-2503-2215
person.identifier.orcid0000-0003-3463-5007
person.identifier.orcid0000-0003-0745-2379
person.identifier.orcid0000-0002-1125-3236
person.identifier.orcid0000-0003-1734-2632
person.identifier.orcid0000-0002-4115-7376
person.identifier.orcid0000-0002-0732-9728
person.identifier.orcid0000-0002-1503-3150
person.identifier.orcid0000-0001-6445-4800
person.identifier.orcid0000-0002-7536-8737
person.identifier.orcid0000-0003-4852-229X
person.identifier.ridI-4068-2018
person.identifier.ridI-4899-2014
person.identifier.ridM-7982-2013
person.identifier.ridF-9455-2010
person.identifier.ridH-4509-2019
person.identifier.scopus-author-id54966693200
person.identifier.scopus-author-id16047229700
person.identifier.scopus-author-id26221759800
person.identifier.scopus-author-id11640594200
person.identifier.scopus-author-id55543341300
person.identifier.scopus-author-id54973914300
person.identifier.scopus-author-id55255798200
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationfd65a624-63f8-46a6-ace9-cba7130693f5
relation.isAuthorOfPublicationfa7f1aa3-adf0-4fa4-8c65-9e6667e2f38e
relation.isAuthorOfPublicationbc1dc7e8-b0f9-4c9f-b5e6-e516c2c083d1
relation.isAuthorOfPublication738128ba-c60a-4065-9fc5-5db4ae883098
relation.isAuthorOfPublication1c212836-a20a-4ed3-9a2f-f2eea50b69cb
relation.isAuthorOfPublicationd78c459d-0021-4a68-bca9-7b4d270958e0
relation.isAuthorOfPublication04a4f743-896b-4867-ac58-1ef5fb23cd0f
relation.isAuthorOfPublicationbfd33c20-e2cb-4cbf-8336-dc526122fcbd
relation.isAuthorOfPublication9eb8216c-2146-4865-a400-819dbbc9f34e
relation.isAuthorOfPublication51b688bc-9d2e-4dae-b2da-c0b1a62bb419
relation.isAuthorOfPublication0845cdd2-0129-4494-8cda-9d9665b23b42
relation.isAuthorOfPublicationf947c05c-89bc-4ae0-8bed-3ea817079416
relation.isAuthorOfPublication4bdac915-08a0-40f4-84e2-501787e5f200
relation.isAuthorOfPublication9fd05a6c-d12e-48c4-9614-15bfae3cfa73
relation.isAuthorOfPublicationc890c74a-abc1-4910-aa70-f0da7b4ad902
relation.isAuthorOfPublication41a82e00-abc8-4071-b622-f674244035e2
relation.isAuthorOfPublication5a3f988b-b188-402c-be9b-16eb14129a2b
relation.isAuthorOfPublicationd2c04968-96e4-4eef-8cb8-52a92e52dce7
relation.isAuthorOfPublicatione1d102bd-8ee6-44e0-954f-6dfbce008791
relation.isAuthorOfPublicationeb5b3ede-84f3-4a29-b796-cd1feac3f082
relation.isAuthorOfPublication1657990f-d92c-4512-89b5-285edcff1a69
relation.isAuthorOfPublication7b97cf3a-690b-4248-be49-47ad33170cee
relation.isAuthorOfPublication49261ced-02e9-4424-bf2e-5151262cdd2e
relation.isAuthorOfPublicationdd58da40-8314-4841-b606-3afa174d2b2d
relation.isAuthorOfPublication833b2172-b6cc-48fa-89be-7a3a1a6260b1
relation.isAuthorOfPublication6c713eec-bfd3-4f2b-9594-89efce325f1d
relation.isAuthorOfPublication.latestForDiscovery04a4f743-896b-4867-ac58-1ef5fb23cd0f

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2024_Hellings_Allergy.pdf
Size:
3.65 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: